Sponsored Links
| Personalised First-Line Therapy Stalls Lung Cancer For Nearly Twice As Long As Chemotherapy |
 |
 |
 |
| Medical News - Lung Cancer | |||
|
Roche today announced results from the first Phase III study with erlotinib (Tarceva®) in Western patients with a genetically mutated type of advanced non-small cell lung cancer (NSCLC)... Read more: Lung Cancer News From Medical News Today
|